TY  - GEN
AU  - Levin,V A
AU  - Uhm,J H
AU  - Jaeckle,K A
AU  - Choucair,A
AU  - Flynn,P J
AU  - Prados,M D
AU  - Bruner,J M
AU  - Chang,S M
AU  - Kyritsis,A P
AU  - Gleason,M J
AU  - Hess,K R
TI  - Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme
SN  - 1078-0432
PY  - 2001///0322
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Brain Neoplasms
KW  - drug therapy
KW  - Cisplatin
KW  - Cyclophosphamide
KW  - Disease-Free Survival
KW  - Dose-Response Relationship, Drug
KW  - Eflornithine
KW  - Female
KW  - Glioblastoma
KW  - Humans
KW  - Lomustine
KW  - Male
KW  - Middle Aged
KW  - Procarbazine
KW  - Prospective Studies
KW  - Time Factors
KW  - Vincristine
KW  - Vindesine
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S
ER  -